Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01430325 · ClinicalTrials.gov registry record · NA
Test of Chamber Pressure to Divers and Chamber Attendants
A NA study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT01430325: Completed NA study, sponsored by Intermountain Health Care.
NCT01430325 is a NA study that has completed, run by Intermountain Health Care. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01430325, a NA study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
SCUBA divers and chamber inside attendants will undergo a brief hyperbaric chamber excursion and will be asked to what chamber pressure they were compressed and what gas they breathed.
Primary Outcome
Participants indicating "I do not know" on depth questionnaire instead of providing a free response guess.
Interventions
- DRUG Hyperbaric Oxygen (1.5 atm abs)
- DRUG Sham Chamber Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01430325 record still lists
NCT01430325 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Hyperbaric Oxygen (1.5 atm abs) is the first listed.
NCT01430325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01430325 about?
NCT01430325 is a clinical study titled "Test of Chamber Pressure to Divers and Chamber Attendants". SCUBA divers and chamber inside attendants will undergo a brief hyperbaric chamber excursion and will be asked to what chamber pressure they were compressed and what gas they breathed.
What is the current status of trial NCT01430325?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2011-07. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01430325?
The interventions under investigation include: Hyperbaric Oxygen (1.5 atm abs) (DRUG), Sham Chamber Session (DRUG).
Who is sponsoring clinical trial NCT01430325?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01430325's enrollment target sits among peer trials
42 1436th of 2000 higher than 555 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia